Home › Calculator › RDY Dividend Calculator 2026
RDY DRIP Calculator & Dividend Yield 2026
0.63% YieldHealthcareDr. Reddy's Laboratories Limited · NYSE
Price: $13.26 · Annual div: $0.0834/share · Frequency: annual · Payout ratio: N/A · Ex-div: 2026-07-24
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
RDY Dividend Yield
RDY (Dr. Reddy's Laboratories Limited) has a dividend yield of 0.63%, based on an annual dividend of $0.0834 per share and a price of $13.26. Over the last 12 months it paid $0.0834 per share — a trailing yield of 0.63%. Dividends are paid annual.
Yield history: over the last 8 payments, RDY's 12-month yield ranged from 0.54% to 2.16%. Full RDY dividend history ↓
Yield on cost: if RDY's dividend keeps growing 11.0% a year, a purchase at today's price would yield 1.06% after 5 years, 1.79% after 10 years and 5.07% after 20 years on the original investment.
RDY DRIP Rate: How Many Shares Your Dividends Buy
With dividends reinvested, a RDY position grows its share count by about 0.61% in the first year at today's price and yield.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When RDY pays your bills
Year your monthly dividend income covers each expense (based on current settings)
RDY Dividend History — Last 29 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-07-24Latest | 2026-08-05 | $0.0834 | 1.25% | $13.99 |
| 2025-07-25 | 2025-08-06 | $0.0915 | 1.15% | $14.94 |
| 2024-07-30 | 2024-08-12 | $0.0808 | 0.54% | $15.08 |
| 2023-07-28 | 2023-08-11 | $0.0965 | 2.16% | $12.51 |
| 2023-07-07 | 2023-08-11 | $0.0976 | 2.00% | $12.51 |
| 2022-08-01 | 2022-08-12 | $0.0757 | 1.49% | $10.30 |
| 2022-07-08 | 2022-07-11 | $0.0774 | 1.30% | $11.17 |
| 2021-07-09 | 2021-08-11 | $0.0673 | 0.89% | $15.04 |
| 2020-07-10 | 2020-08-17 | $0.0667 | — | — |
| 2019-07-12 | 2019-08-15 | $0.0564 | — | — |
| 2018-07-13 | 2018-08-09 | $0.0584 | — | — |
| 2017-07-13 | 2017-08-10 | $0.2939 | — | — |
| 2016-07-14 | 2016-08-09 | $0.0599 | — | — |
| 2015-07-08 | 2015-08-17 | $0.0626 | — | — |
| 2014-08-01 | 2014-08-15 | $0.0583 | — | — |
| 2013-07-10 | 2013-08-15 | $0.0491 | — | — |
| 2012-06-27 | 2012-08-06 | $0.2290 | — | — |
| 2011-06-29 | 2011-08-11 | $0.0509 | — | — |
| 2011-06-14 | 2011-06-23 | $0.1321 | — | — |
| 2010-06-30 | 2010-08-17 | $0.0483 | — | — |
| 2009-07-02 | 2009-08-12 | $0.0261 | — | — |
| 2008-07-03 | 2008-08-18 | $0.0178 | — | — |
| 2007-07-06 | 2007-08-10 | $0.0186 | — | — |
| 2006-07-07 | 2006-08-21 | $0.0107 | — | — |
| 2005-07-07 | 2005-08-16 | $0.0115 | — | — |
| 2004-07-15 | 2004-08-24 | $0.0108 | — | — |
| 2003-08-07 | 2003-10-02 | $0.0109 | — | — |
| 2002-03-20 | — | $0.0400 | — | — |
| 2002-03-20 | — | $0.0400 | — | — |
About Dr. Reddy's Laboratories Limited (RDY) — Dividend Analysis 2026
Dr. Reddy's Laboratories Limited, alongside its associated companies, functions as a holistic pharmaceutical entity with a global footprint. Its business operations are divided into several key divisions. The Global Generics segment is responsible for the manufacturing and sale of both prescription and over-the-counter finished pharmaceutical products. These offerings are available either under a proprietary brand or as generic formulations that are therapeutically identical to their branded equivalents. This segment also includes the company's biologics ventures. The Pharmaceutical Services and Active Ingredients (PSAI) division focuses on producing and distributing active pharmaceutical ingredients (APIs) and chemical intermediates, which serve as crucial building blocks for final drug products. Additionally, PSAI provides contract research services and produces custom-specified APIs and steroids for clients. The Proprietary Products segment is dedicated to the research and advancement of unique pharmaceutical formulations. The Others segment is actively involved in developing treatments, primarily for oncology (cancer) and inflammatory conditions. Dr. Reddy's addresses a broad spectrum of therapeutic areas, including gastrointestinal issues, cardiovascular health, diabetes, dermatological concerns, cancer, respiratory diseases, oral health, urological disorders, and nephrological conditions. The company has also established a partnership with Curis, Inc., centered on the discovery, development, and commercialization of small molecule antagonists designed for immuno-oncology and precision oncology targets. Founded in 1984, Dr. Reddy's Laboratories Limited maintains its principal office in Hyderabad, India.
RDY Dividend & DRIP — Frequently Asked Questions
What is RDY's dividend yield?
RDY (Dr. Reddy's Laboratories Limited) has a dividend yield of 0.63%, based on an annual dividend of $0.0834 per share and a price of $13.26. Over the last 12 months it paid $0.0834 per share — a trailing yield of 0.63%. Dividends are paid annual.
How much does $10,000 in RDY pay in dividends?
$10,000 in RDY at a 0.63% yield pays about $63 a year ($5 a month) before taxes. With DRIP, reinvested dividends buy more shares and that income compounds.
What is the DRIP rate for RDY?
With dividends reinvested, a RDY position grows its share count by about 0.61% in the first year at today's price and yield.
How do I calculate RDY dividend reinvestment (DRIP) returns?
Enter your starting amount, monthly contribution and time horizon in the RDY DRIP calculator at the top of this page. It reinvests each payout into new shares at the projected price, grows the dividend at the rate you choose and shows yearly income, share count, portfolio value and yield on cost. You can switch DRIP off to compare.
When is RDY's next ex-dividend date?
RDY's next ex-dividend date has not been announced yet; the most recent one was 2026-07-24. RDY pays dividends annual. Buy before the ex-dividend date to receive the next payment.
What is RDY's dividend growth rate?
RDY's dividend changed -8.8% over the last year and 11.0% a year on average over five years.
Similar dividend stocks to RDY
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full RDY DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open RDY position with:
🌍 RDY Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold RDY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.63% | -2.17% | $63 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.54% | -2.26% | $54 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.50% | -2.30% | $50 / yr |
| 🇬🇧 UK ISA | 0% | 0.63% | -2.17% | $63 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.57% | -2.23% | $57 / yr |
| 🇨🇦 TFSA | 0% | 0.63% | -2.17% | $63 / yr |
| 🇨🇦 CA Taxable | 25% | 0.47% | -2.33% | $47 / yr |
| 🇦🇺 Super (pension) | 15% | 0.54% | -2.26% | $54 / yr |
| 🇦🇺 AU Taxable | 30% | 0.44% | -2.36% | $44 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.46% | -2.34% | $46 / yr |
| 🇫🇷 FR Taxable | 30% | 0.44% | -2.36% | $44 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 RDY Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.08/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 RDY Dividend Payment Schedule
RDY pays annually — 1 payment per year.
📊 RDY vs Healthcare Benchmarks
How RDY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RDY sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ RDY Insider Activity
No recent SEC filings reported in the last 90 days.Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare RDY with peers: RDY vs BMRN · RDY vs EHC · RDY vs ELAN
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where RDY earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RDY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Dr. Reddy's Laboratories Limited (RDY) is currently trading at $13.26, 15% below its 52-week high. The current dividend yield is 0.63% based on an annual payout of $0.0834 per share.
RDY (Dr. Reddy's Laboratories Limited) — 0.63% Dividend Yield Analysis
Dr. Reddy's Laboratories Limited (RDY) is a healthcare stock currently trading at $13.26 with a dividend yield of 0.63%. It pays an annual dividend of $0.0834 per share. Over the past 5 years, RDY has grown its dividend at a compound annual rate of 11.0%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest RDY News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
How investors use the RDY dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.